A citation-based method for searching scientific literature

Leslie J Burke, Jan Sevcik, Gaetana Gambino, Emma Tudini, Eliseos J Mucaki, Ben C Shirley, Phillip Whiley, Michael T Parsons, Kim De Leeneer, Sara Gutiérrez-Enríquez, Marta Santamariña, Sandrine M Caputo, Elizabeth Santana Dos Santos, Jana Soukupova, Marketa Janatova, Petra Zemankova, Klara Lhotova, Lenka Stolarova, Mariana Borecka, Alejandro Moles-Fernández, Siranoush Manoukian, Bernardo Bonanni, Stacey L Edwards, Marinus J Blok, Thomas van Overeem Hansen, Maria Rossing, Orland Diez, Ana Vega, Kathleen B M Claes, David E Goldgar, Etienne Rouleau, Paolo Radice, Paolo Peterlongo, Peter K Rogan, Maria Caligo, Amanda B Spurdle, Melissa A Brown. Hum Mutat 2018
Times Cited: 9







List of co-cited articles
58 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
E Santana Dos Santos, S M Caputo, L Castera, M Gendrot, A Briaux, M Breault, S Krieger, P K Rogan, E J Mucaki, L J Burke,[...]. Breast Cancer Res Treat 2018
14
66

Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brooke L Brewster, Francesca Rossiello, Juliet D French, Stacey L Edwards, Ming Wong, Ania Wronski, Phillip Whiley, Nic Waddell, Xiaowei Chen, Betsy Bove,[...]. Hum Mutat 2012
40
66

A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.
D Gareth R Evans, Elke M van Veen, Helen J Byers, Andrew J Wallace, Jamie M Ellingford, Glenda Beaman, Javier Santoyo-Lopez, Timothy J Aitman, Diana M Eccles, Fiona I Lalloo,[...]. Am J Hum Genet 2018
31
44

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
44

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
44


Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
456
33

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
33

A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
Eliseos J Mucaki, Natasha G Caminsky, Ami M Perri, Ruipeng Lu, Alain Laederach, Matthew Halvorsen, Joan H M Knoll, Peter K Rogan. BMC Med Genomics 2016
11
33

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
33

A guide for functional analysis of BRCA1 variants of uncertain significance.
Gaël A Millot, Marcelo A Carvalho, Sandrine M Caputo, Maaike P G Vreeswijk, Melissa A Brown, Michelle Webb, Etienne Rouleau, Susan L Neuhausen, Thomas v O Hansen, Alvaro Galli,[...]. Hum Mutat 2012
84
33

Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.
Eugenia Fraile-Bethencourt, Alberto Valenzuela-Palomo, Beatriz Díez-Gómez, Mar Infante, Mercedes Durán, Germán Marcos, Enrique Lastra, Susana Gómez-Barrero, Eladio A Velasco. Breast Cancer Res Treat 2018
5
60

The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
Sven Diederichs, Lorenz Bartsch, Julia C Berkmann, Karin Fröse, Jana Heitmann, Caroline Hoppe, Deetje Iggena, Danny Jazmati, Philipp Karschnia, Miriam Linsenmeier,[...]. EMBO Mol Med 2016
125
33

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
33

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families.
Laurent Castéra, Valentin Harter, Etienne Muller, Sophie Krieger, Nicolas Goardon, Agathe Ricou, Antoine Rousselin, Germain Paimparay, Angelina Legros, Olivia Bruet,[...]. Genet Med 2018
33
33

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.
F Lhota, P Zemankova, P Kleiblova, J Soukupova, M Vocka, V Stranecky, M Janatova, H Hartmannova, K Hodanova, S Kmoch,[...]. Clin Genet 2016
26
22

Isolation and initial characterization of the BRCA2 promoter.
P L Davis, A Miron, L M Andersen, J D Iglehart, J R Marks. Oncogene 1999
50
22


Complex regulation of the BRCA1 gene.
C F Xu, J A Chambers, E Solomon. J Biol Chem 1997
126
22

GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter.
E Atlas, M Stramwasser, K Whiskin, C R Mueller. Oncogene 2000
43
22

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.
Amanda B Spurdle, Phillip J Whiley, Bryony Thompson, Bingjian Feng, Sue Healey, Melissa A Brown, Christopher Pettigrew, Christi J Van Asperen, Margreet G E M Ausems, Anna A Kattentidt-Mouravieva,[...]. J Med Genet 2012
66
22

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Jessica Kao, Keyan Salari, Melanie Bocanegra, Yoon-La Choi, Luc Girard, Jeet Gandhi, Kevin A Kwei, Tina Hernandez-Boussard, Pei Wang, Adi F Gazdar,[...]. PLoS One 2009
499
22

Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants.
Maxime P Vallée, Tonya L Di Sera, David A Nix, Andrew M Paquette, Michael T Parsons, Russel Bell, Andrea Hoffman, Frans B L Hogervorst, David E Goldgar, Amanda B Spurdle,[...]. Hum Mutat 2016
39
22

Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.
Natasha G Caminsky, Eliseos J Mucaki, Ami M Perri, Ruipeng Lu, Joan H M Knoll, Peter K Rogan. Hum Mutat 2016
22
22

Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
Miguel de la Hoya, Omar Soukarieh, Irene López-Perolio, Ana Vega, Logan C Walker, Yvette van Ierland, Diana Baralle, Marta Santamariña, Vanessa Lattimore, Juul Wijnen,[...]. Hum Mol Genet 2016
48
22

Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.
Jodi M Saunus, Juliet D French, Stacey L Edwards, Dianne J Beveridge, Esme C Hatchell, Sarah A Wagner, Sandra R Stein, Andrew Davidson, Kaylene J Simpson, Glenn D Francis,[...]. Cancer Res 2008
35
22

Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:psiBRCA1 recombination.
Melissa A Brown, Li-Jan Lo, Aurélie Catteau, Chun-Fang Xu, Geoffrey J Lindeman, Shirley Hodgson, Ellen Solomon. Hum Mutat 2002
25
22

Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR.
Megan P Hitchins, Robert W Rapkins, Chau-To Kwok, Sameer Srivastava, Justin J L Wong, Levon M Khachigian, Patsie Polly, Jack Goldblatt, Robyn L Ward. Cancer Cell 2011
108
22

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
22

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012
181
22

A second DNA binding site in human BRCA2 promotes homologous recombination.
Catharina von Nicolai, Åsa Ehlén, Charlotte Martin, Xiaodong Zhang, Aura Carreira. Nat Commun 2016
25
22

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
717
22

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Amanda B Spurdle, Fergus J Couch, Michael T Parsons, Lesley McGuffog, Daniel Barrowdale, Manjeet K Bolla, Qin Wang, Sue Healey, Rita Schmutzler, Barbara Wappenschmidt,[...]. Breast Cancer Res 2014
56
22

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Andrew Tutt, Holly Tovey, Maggie Chon U Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazinska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett-Lee,[...]. Nat Med 2018
295
22

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.
Sandrine Caputo, Louisa Benboudjema, Olga Sinilnikova, Etienne Rouleau, Christophe Béroud, Rosette Lidereau. Nucleic Acids Res 2012
58
22

A general framework for estimating the relative pathogenicity of human genetic variants.
Martin Kircher, Daniela M Witten, Preti Jain, Brian J O'Roak, Gregory M Cooper, Jay Shendure. Nat Genet 2014
22

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
22

Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer.
Stéphanie Lheureux, Bernard Lambert, Sophie Krieger, Angelina Legros, Dominique Vaur, Christophe Denoyelle, Pascaline Berthet, Laurent Poulain, Agnès Hardouin. Breast Cancer Res Treat 2011
16
22


Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter.
Jinhua Wang, Chunjing Bian, Jing Li, Fergus J Couch, Kangjian Wu, Robert Chunhua Zhao. J Biol Chem 2008
22
22

Molding BRCA2 function through its interacting partners.
Juan S Martinez, Céline Baldeyron, Aura Carreira. Cell Cycle 2015
15
22

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
22

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Robert L Coleman, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew Clamp, Giovanni Scambia,[...]. Lancet 2017
575
22

Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
P S Brzovic, P Rajagopal, D W Hoyt, M C King, R E Klevit. Nat Struct Biol 2001
361
22

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.
Elizabeth Santana Dos Santos, François Lallemand, Leslie Burke, Dominique Stoppa-Lyonnet, Melissa Brown, Sandrine M Caputo, Etienne Rouleau. Cancers (Basel) 2018
7
28

BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.
D A Bochar, L Wang, H Beniya, A Kinev, Y Xue, W S Lane, W Wang, F Kashanchi, R Shiekhattar. Cell 2000
414
22

Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
Claude Houdayer, Virginie Caux-Moncoutier, Sophie Krieger, Michel Barrois, Françoise Bonnet, Violaine Bourdon, Myriam Bronner, Monique Buisson, Florence Coulet, Pascaline Gaildrat,[...]. Hum Mutat 2012
144
22

Improved splice site detection in Genie.
M G Reese, F H Eeckman, D Kulp, D Haussler. J Comput Biol 1997
22

RAD51C is a susceptibility gene for ovarian cancer.
Liisa M Pelttari, Tuomas Heikkinen, Deborah Thompson, Anne Kallioniemi, Johanna Schleutker, Kaija Holli, Carl Blomqvist, Kristiina Aittomäki, Ralf Bützow, Heli Nevanlinna. Hum Mol Genet 2011
92
22

Two decades after BRCA: setting paradigms in personalized cancer care and prevention.
Fergus J Couch, Katherine L Nathanson, Kenneth Offit. Science 2014
199
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.